Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into...
Main Authors: | Swati Sathe, Jen Ware, Jamie Levey, Eileen Neacy, Robi Blumenstein, Simon Noble, Alzbeta Mühlbäck, Anne Rosser, G. Bernhard Landwehrmeyer, Cristina Sampaio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.667420/full |
Similar Items
-
The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
by: Natalia P. Rocha, et al.
Published: (2018-11-01) -
Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington’s Disease Using the Enroll-HD Global Platform
by: Alexander L. Symonds, et al.
Published: (2021-05-01) -
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
by: Daisy Abreu, et al.
Published: (2021-07-01) -
Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort
by: Jannis Achenbach, et al.
Published: (2021-03-01) -
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD): protocol for a randomised feasibility study
by: Emma Yhnell, et al.
Published: (2018-02-01)